Horus Pharma India Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 0.50 M
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 Cr
- Satisfied Charges ₹ 2.00 Cr
- Revenue Growth -11.12%
- Profit Growth -65.78%
- Ebitda -41.38%
- Net Worth 8.34%
- Total Assets 11.84%
About Horus Pharma India
Horus Pharma India Limited (HPIL) is a Public Limited Indian Non-Government Company incorporated in India on 17 March 1994 and has a history of 30 years and 11 months. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.50 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chandrakant Malpani, Sanjay Kalantri, and Harinarayan Chichani serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1994PLC077147
- Company No.
077147
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Mar 1994
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Horus Pharma India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrakant Malpani  | Managing Director | 01-Dec-2005 | Current |
| Sanjay Kalantri | Managing Director | 28-Sep-2008 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harinarayan Chichani | Director | 01-Dec-2005 | Current |
Financial Performance of Horus Pharma India.
Horus Pharma India Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 11.12% decrease. The company also saw a substantial fall in profitability, with a 65.78% decrease in profit. The company's net worth moved up by a moderate rise of 8.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Horus Pharma India?
In 2020, Horus Pharma India had a promoter holding of 99.88% and a public holding of 0.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Century Logistic Infrastructures LlpChandrakant Malpani is a mutual person
- Suraaj Agrofarms Llp
Chandrakant Malpani is a mutual person
- Metro Biotech Private Limited
Chandrakant Malpani, Sanjay Kalantri and 1 more are mutual person
- Wire Craft Solution Technology Private Limited
Chandrakant Malpani is a mutual person
- Prakalp Private Limited
Chandrakant Malpani, Sanjay Kalantri and 1 more are mutual person
- Future Auto Private Limited
Chandrakant Malpani, Sanjay Kalantri and 1 more are mutual person
Charges (Loans)
₹2.50 Cr
₹2.00 Cr
Charges Breakdown by Lending Institutions
- Others : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2019 | Others | ₹2.50 Cr | Open |
| 29 Jun 2006 | The Akola Urban Co-Op. Bank Limtied | ₹2.00 Cr | Satisfied |
How Many Employees Work at Horus Pharma India?
Unlock and access historical data on people associated with Horus Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Horus Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Horus Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
